Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
AMGEN
Scientific Title
A Phase 1, First-in-Human, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 in Subjects With Advanced Solid Tumors With a Specific KRAS Mutation